These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1026 related articles for article (PubMed ID: 19668188)

  • 1. The Ink4/Arf locus is a barrier for iPS cell reprogramming.
    Li H; Collado M; Villasante A; Strati K; Ortega S; Cañamero M; Blasco MA; Serrano M
    Nature; 2009 Aug; 460(7259):1136-9. PubMed ID: 19668188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells.
    Utikal J; Polo JM; Stadtfeld M; Maherali N; Kulalert W; Walsh RM; Khalil A; Rheinwald JG; Hochedlinger K
    Nature; 2009 Aug; 460(7259):1145-8. PubMed ID: 19668190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of higher-order chromatin structure of the INK4/ARF locus in human senescent cells.
    Hirosue A; Ishihara K; Tokunaga K; Watanabe T; Saitoh N; Nakamoto M; Chandra T; Narita M; Shinohara M; Nakao M
    Aging Cell; 2012 Jun; 11(3):553-6. PubMed ID: 22340434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
    Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
    Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.
    Gonzalez S; Klatt P; Delgado S; Conde E; Lopez-Rios F; Sanchez-Cespedes M; Mendez J; Antequera F; Serrano M
    Nature; 2006 Mar; 440(7084):702-6. PubMed ID: 16572177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
    Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
    PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dosage of Patz1 modulates reprogramming process.
    Ma H; Ow JR; Tan BC; Goh Z; Feng B; Loh YH; Fedele M; Li H; Wu Q
    Sci Rep; 2014 Dec; 4():7519. PubMed ID: 25515777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-aging activity of the Ink4/Arf locus.
    Matheu A; Maraver A; Collado M; Garcia-Cao I; Cañamero M; Borras C; Flores JM; Klatt P; Viña J; Serrano M
    Aging Cell; 2009 Apr; 8(2):152-61. PubMed ID: 19239418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J; Fried M
    Oncogene; 2001 Nov; 20(50):7447-52. PubMed ID: 11704876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mechanism of inactivation of the INK4/ARF locus.
    Gonzalez S; Serrano M
    Cell Cycle; 2006 Jul; 5(13):1382-4. PubMed ID: 16855387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
    Kawamura T; Suzuki J; Wang YV; Menendez S; Morera LB; Raya A; Wahl GM; Izpisúa Belmonte JC
    Nature; 2009 Aug; 460(7259):1140-4. PubMed ID: 19668186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ink4-Arf locus in cancer and aging.
    Sherr CJ
    Wiley Interdiscip Rev Dev Biol; 2012; 1(5):731-41. PubMed ID: 22960768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice.
    Fuster JJ; Molina-Sánchez P; Jovaní D; Vinué Á; Serrano M; Andrés V
    Atherosclerosis; 2012 Mar; 221(1):98-105. PubMed ID: 22226369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines.
    Roberti A; Rizzolio F; Lucchetti C; de Leval L; Giordano A
    Cell Cycle; 2011 Jan; 10(1):127-34. PubMed ID: 21200153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescence impairs successful reprogramming to pluripotent stem cells.
    Banito A; Rashid ST; Acosta JC; Li S; Pereira CF; Geti I; Pinho S; Silva JC; Azuara V; Walsh M; Vallier L; Gil J
    Genes Dev; 2009 Sep; 23(18):2134-9. PubMed ID: 19696146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline.
    Carrasco-Garcia E; Arrizabalaga O; Serrano M; Lovell-Badge R; Matheu A
    Aging Cell; 2015 Aug; 14(4):710-4. PubMed ID: 25990896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression.
    Aguilo F; Zhou MM; Walsh MJ
    Cancer Res; 2011 Aug; 71(16):5365-9. PubMed ID: 21828241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.
    Burd CE; Jeck WR; Liu Y; Sanoff HK; Wang Z; Sharpless NE
    PLoS Genet; 2010 Dec; 6(12):e1001233. PubMed ID: 21151960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.